AlphaCrest Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

AlphaCrest Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,034	Closed	-$2.62M	–	1484
2021 Q3	$2.62M	Buy	44,034 +22,780	+107%	+$1.35M	0.14%	193
2021 Q2	$1.45M	Buy	21,254 +7,442	+54%	+$485K	0.06%	491
2021 Q1	$958K	Buy	+13,812	New	+$1.06M	0.05%	515
2019 Q3	–	Sell	-29,800	Closed	-$1.75M	–	1376
2019 Q2	$1.75M	Buy	+29,800	New	+$1.54M	0.15%	188

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AlphaCrest Capital Management's ARNA Position: Q4 2021 in Review

AlphaCrest Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 44,034 shares — an estimated $2.62M sold.

AlphaCrest Capital Management first reported a position in ARNA in Q2 2019 and held it in 4 quarters. The position peaked at $2.62M in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

AlphaCrest Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
AlphaCrest Capital Management sold 44,034 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $2.62M.
AlphaCrest Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 4 quarters.
AlphaCrest Capital Management's Arena Pharmaceuticals Inc position peaked at $2.62M in Q3 2021.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.